Hyaluronidase-nvhy
Generic Name: hyaluronidase-nvhy
Manufactured by BRISTOL-MYERS SQUIBB. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: NIVOLUMAB (600MG); HYALURONIDASE-NVHY (10000 UNITS PER 5ML(120MG/2000UNITS PER ML)). Application: BLA761429.
Overview
Manufactured by BRISTOL-MYERS SQUIBB. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: NIVOLUMAB (600MG); HYALURONIDASE-NVHY (10000 UNITS PER 5ML(120MG/2000UNITS PER ML)). Application: BLA761429.
Dosage
Available as injectable for injection use.
Related Medications
Curcuma Longa,hydrolyzed Collagen,kojic Acid,adenosine
curcuma longa,hydrolyzed collagen,kojic acid,adenosine
Adenosine Receptor Agonist [EPC]
Deeply replenishes moisture, restores elasticity, and enhances skin firmness.
Potassium Phosphate, Monobasic
potassium phosphate, monobasic
DESCRIPTION Each tablet contains potassium acid phosphate 500 mg. Each tablet yields approximately 114 mg of phosphorus and 144 mg of potassium or 3.7 mEq. Inactive ingredients: Magnesium stearate, microcrystalline cellulose, silicon dioxide, starch, stearic acid.
Cedazuridine And Decitabine
cedazuridine and decitabine
Nucleoside Metabolic Inhibitor [EPC]
11 DESCRIPTION Decitabine Decitabine is a nucleoside metabolic inhibitor. Decitabine is a white to off-white solid with the molecular formula of C 8 H 12 N 4 O 4 and a molecular weight of 228.21 daltons. Its international union of pure and applied chemistry (IUPAC) chemical name is 4-amino-1-[(2 R ,4 S ,5 R )-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2(1 H )-one and it has the following structural formula: Cedazuridine Cedazuridine is a cytidine deaminase inhibitor.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.